FN1 and myeloid sarcoma: We outline the beneficial roles of Fn in the neurovascular unit and the detrimental roles of Fn in MS pathology and discuss therapeutic strategies and agents to prevent Fn aggregation and/or to overcome Fn-mediated inhibition of remyelination.